The Department of Toxicology and Military Pharmacy (DTMF) as a part of the Faculty of Military Health Sciences, University of Defense was founded in 1951. During more than sixty years of its existence, the Department has gained reputation of a highly qualified research centre focused on the effects of chemical warfare agents (CWA), development of antidotes including antidotal means for the Army, solving questions with medical protection against highly toxic agents and educational activities, both pre-and postgradual including international cooperation. Meetings and scientific conferences organized by the Department have been attended by recognized scientists. Its future activities are focused on further studies and development of medical countermeasures including means against effects of CWA preferably nerve agents. There is real and concrete contribution of the Department to the improvement of medical protection of armed forces against the effects of CWA.
INTRODUCTION
The history of the DTMF is as long as the history of the Military Medical Academy: the Department of Toxicology was founded more than sixty years ago as a part of the J. E. Purkyně Military Medical Academy (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) , subsequently the Military Medical Research and Postgraduate Training Institute JEP and then, once again, the Military Medical Academy (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) . Since 2004, the Academy has been transformed into a part of the University of Defence as its 3rd Faculty of Military Health Sciences, including Department of Toxicology and on September 1, DTMF was established by integration of Department of Toxicology and selected parts of Centre of Advanced Studies and Department of Public Health.; COL Assoc. Prof. Pharm.Dr. Daniel Jun, PhD. has been appointed as the Head (2014). material in 1951 was one typewriter and two protective masks (Fig. 1 ).
Research was not performed and all activities were focused on education only. The activities dealing with education continued resulting in elaboration of different textbooks of local and national importance [1] . However, at the end of the fifties, some instruments were obtained and research of CWA was beginning. Firstly, it was focused on asphyxiating agents and vesicants, later on on nerve agents. In the sixties and seventies, a new type of CWA was studied -psychotomimetic agents beginning with LSD-25 followed by anticholinergic hallucinogen BZ agent. The research finished by development of a new antidote against BZ -7-methoxytacrine [2, 3] ; education including writing of new textbooks continued [4] [5] [6] .
Research of the nerve agents was dedicated to antidotes -parasympatholytics and reactivators. After detailed studies, two anticholinergic drugs (atropine, benactyzine) and two reactivators of nerve agent inhibited acetylcholinesterase (trimedoxime, methoxime) were introduced into the Army for medical use. The most effective reactivator HI-6 was introduced into this antidotal spectrum, too. Simultaneously, prophylactics against nerve agents were studied and as a result of improvement of prophylaxis, new prophylactic antidote was developed containing pyridostigmine, benactyzine and trihexyphenidyle, having better prophylactic effectivity than pyridostigmine alone (it was/is used in some Armies till now).
PAST ACTIVITIES
Research of the department led to concrete results: Synthesis of tetrahydroaminoacridine derivatives • (hundreds compounds), the best of which for clinical and antidotal use was 7-methoxytacrine (7-MEOTA). The development of tablets and injections was finished and the drug was tested on volunteers and introduced into the Armed Forces as a specific antidote against psychotomimetic agent BZ ( Fig. 2) 
PRESENT ACTIVITIES
DTMF is a unique department both in the Czech Armed Forces and throughout the whole country. Its activities are focused on the following areas: executive activities such as diagnosis, therapy and prevention of effects of highly toxic compounds (including CWA), decontamination principles of persons, assessment of trends for the future in this field, educational activities in pre-and postgraduate systems, research, development and testing of new protective chemical equipment from the medical point of view including materials for the Armed Forces needs, consultation of environmental issues and accidents connected with the release of toxic chemicals. DTMF cooperates with national (State Office for Nuclear Safety) and international (Organisation for Prohibition of Chemical Weapons, OPCW) authorities for control of chemical weapons, and, in the field of research and education, with many civilian and military research institutes.
After the velvet revolution in 1989, the Department was moved into a new phase of its history. Cooperation with NATO countries was increased as well as inclusion of the DTMF into international research. These activities were summarized in some publications [7, 8] .
To fulfil the tasks of the Department, it is divided into two groups -Biochemical Group and Group for Experimental Therapy. The first group uses a biochemical and analytical laboratory, laboratory for organic synthesis, and decontamination laboratory. The list of laboratories allotted to the second group is as follows: toxicological, pharmacological, neurobehavioral and genotoxicological laboratory. The department laboratories contain standard equipment such as spectrophotometers, fluorimeters, microscopes, centrifuges etc.; however, in addition, DTMF has developed a unique inhalation chamber for studies of inhalation toxicity of nerve agents in rodents, and some analytical instruments including GC-MS, HPLC and others are included. If necessary, neurobehavioral research is carried out by means of some instruments and techniques enabling the researchers to test various nervous functions of experimental animals in more than 40 parameters with the help of Functional Observational Battery. Certain special methods (COMET assay, etc.) are applied for genotoxicity testing. The developed structure and equipment facilitates characterization of the analyzed agents according to different aspects ranging from the information about the agent through its physicochemical and biological features up to the practical output.
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EDUCATION ACTIVITIES
Education consists of pregradual study of military students of medicine and pharmacy as well as students of bachelors programs. It contains lectures, practical seminars and training not only for military students but also for military medical officers and other soldiers connected to CBRN protection (chemical part). Postgradual study is organized in the accredited doctoral programmes, with "toxicology" on a high professional level. The Department fulfils also other activities such as lectures for the rescue system and other civilian and military institutions. DTMF guarantees specialized preparation of all members of Army missions abroad before starting their mission including medical doctors, nurses, and non medical personnel, organizes exercises of different programs (from students to highly specialized experts) and education is also realized for NATO members and civilian organisations.
According to the achieved results and literature survey, new textbooks dealing with different aspects of military toxicology were elaborated [9] [10] [11] [12] [13] .
RESEARCH ACTIVITIES
The results of research are not only presented as the contributions in specialized scientific literature but also as antidotal means introduced into the Army:
The newest prophylactic antidote containing HI-6 • was introduced into the Czech Army; because of impossibility to be administered orally, a transdermal way of administration (patch impregnated with HI-6) was used (TRANSANT). TRANSANT was introduced into the Armed Forces as a prophylactic antidote of a new generation. When both prophylactics (PANPAL and TRANSANT) are administered simul- taneously, the achieved prophylaxis is potentiated and represents the best prophylactic protection against nerve agents worldwide (Fig. 3) . For diagnostic purposes, a prototype kit for • determining blood acetylcholinesterase activity and its reactivation was developed and used for measuring in various exercises.
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In connection with the so-called "Gulf Syndrome", • the research program was focused on effects of low-level concentrations of sarin and soman during an inhalation exposure. It was demonstrated that sublethal doses (without clinical symptoms) can cause different effects (neurobehavioral, biochemical) emerging weeks or months after the exposure. A new prophylactic approach was studied in coop-• eration with the USA. It is based on administration of purified butyrylcholinesterase acting as "scavenger" and binding a nerve agent before it reaches target organs. These results are very prospective and, at present, the experiments are in progress. A similar problem using other enzymes (phosphotriesterases, phoshorylphosphatases) is being solved in cooperation with the CRSSA, France; the attention has been paid to pseudocatalytic scavengers, too. Synthesis of new reactivators, aimed at obtaining • more effective reactivators, is another direction of the contemporary research. DTMF participates in the development of a new • three chambered wet-dry autoinjector containing atropine, HI-6 and diazepam (MULTIPEN HED) (Fig. 4) The complex kit for medical treatment of intox-• ication with CWA -M-9 special aid (role 1-3) was also developed. Publications in Czech or foreign Journals (books); • use of some results to obtain different academic degrees (Professor, Associate Professor, PhD).
INTERNATIONAL COOPERATION
In the field of developing prophylactic and therapeutical antidotes against nerve agents and organophos- The Department was active in cooperating with the Organization for Prohibition of Chemical Weapons (The Hague). This activity was shown at the Conference on Disarmament (CD) in the past when CWC was formulated. After 1989, four documents were presented. It would be of interest that it was for the first time in the CD negotiation history that antidotes against CWA were openly published ( [15] ( Fig. 6) . Elsevier also published (2012) the book of J. Bajgar "Nerve Agents Poisoning and its Treatment in Schematic Figures and Tables" [16] . The book elaborated in cooperation with Slovak collegues was a common publication on chemical and biological weapons [17] . 
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